Skip to main content

Table 3 Morbidity rate, cost difference between patients with and without complications, and expected savings per patient receiving goal-directed fluid therapy (GDFT)

From: Potential return on investment for implementation of perioperative goal-directed fluid therapy in major surgery: a nationwide database study

Surgery Morbidity rate, % Cost difference between patients with and without complications, dollar Potential savings per patient with GDFT, dollara
All 37.5 11,824 754–1286
AAA open repair 64.9 23,383 2580–4401
Vascular bypass 26.3 15,130 676–1154
Esophagectomy 67.7 30,542 3515–5996
Gastrectomy 20.2 15,153 520–888
Colectomy 43.3 13,096 964–1644
Resection of rectum 33.6 10,937 625–1066
Hepatectomy 34.3 17,043 994–1695
Pancreatectomy 47.5 23,071 1863–3178
Cystectomy 58.9 15,150 1517–2588
F&H fracture repair 38.5 5413 354–604
  1. AAA abdominal aortic aneurysm, F&H femur and hip
  2. aFor patients with valid cost data, unadjusted
\